Introduction
============

Patients with bacterial sepsis often suffer from multiorgan failure. No reliable parameter exists for the exact estimation of the liver function. The indocyaningreen test (ICG test) showed a correlation between liver function and mortality rate. The new maximal liver function capacity test (LiMAx test) is a real-time method to investigate the liver function.

Methods
=======

Thirty septic patients were prospectively included in the study. The LiMAx test was performed on days 0, 2, 5 and 10 after sepsis onset and was compared with ICG test and liver-specific laboratory parameters. Primary endpoint was the mortality rate after 90 days. Secondary endpoint was the comparison with the ICG test.

Results
=======

The LiMAx test showed low results initially with increasing values on days 5 and 10. The 90-day mortality rate in patients with a low LiMAx test on day 2 (\<100 μg/kg/hour) was significantly higher than in patients with a LiMAx test \>100 μg/kg/hour. The LiMAx test was comparable with the ICG test. Patients with indication for renal replacement therapy during hospital treatment showed significantly lower LiMAx values than patients without dialysis. See Figure [1](#F1){ref-type="fig"}.
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Conclusion
==========

With the LiMAx test we can detect a liver dysfunction in septic patients early on days 0 to 2. The LiMAx test is equal with the ICG test and a result of \<100 μg/kg/hour on day 2 suggests a low probability of survival in septic patients.
